{"id":"W1993274621","doi":"10.1002/hep.26276","title":"Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype1 HCV: SILEN-C1 trial","year":2013,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"National Institute on Drug Abuse","keywords":"Ribavirin; Medicine; Gastroenterology; Internal medicine; Rash; Pegylated interferon; Adverse effect; Placebo; Hepatitis C virus; Dosing; Boceprevir; Pharmacology; Immunology; Virus; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000120536,0.0003333764,0.000808863,0.000290874,0.00007416464,0.00002969939,0.0001171212,0.0002356072,0.0008302091],"category_scores_gemma":[0.00008533975,0.0002239263,0.00004312673,0.0002998042,0.0002968858,0.0001569036,0.00007882951,0.0004207896,0.0003053902],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005189488,"about_ca_system_score_gemma":0.0003822195,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004766658,"about_ca_topic_score_gemma":0.007882333,"domain_scores_codex":[0.9977294,0.0003321042,0.000419464,0.0005605509,0.0002894975,0.0006689417],"domain_scores_gemma":[0.9988278,0.0001637327,0.0001056955,0.0004634036,0.0001770168,0.0002624131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02815934,0.0007478971,0.9387072,0.00006955569,0.0001868716,0.0001815783,0.0003263361,0.000001032274,0.0001299743,0.00003399712,0.0002880426,0.03116822],"study_design_scores_gemma":[0.2979009,0.08973937,0.5959007,0.0003398861,0.0002444518,0.00006896926,0.00007243744,0.003895619,0.0009568682,0.00006371033,0.01010458,0.0007124515],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942925,0.000333062,0.0000135911,0.000560344,0.000079724,0.003310678,0.00001702931,0.00006526682,0.001327793],"genre_scores_gemma":[0.9982214,0.0002704269,0.0001437959,0.000136073,0.00005272446,0.0005007687,0.0001683311,0.00005986025,0.0004466479],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3428064,"threshold_uncertainty_score":0.9131451,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01591017208913845,"score_gpt":0.2674205272136614,"score_spread":0.251510355124523,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}